BMC Cardiovascular Disorders is pleased to welcome submissions to this thematic series. All work highlighting current progress and challenges in the diagnosis and treatment of cardiovascular disorders will be considered.
We are recruiting new Associate Editors to join our international Editorial Board, helping to provide expertise on a wide range of subjects within the area of disorders of the heart and circulatory system
Perhaps the outcome was unexpected? Or maybe you haven't had a chance to analyse it? Or it just didn't make it into the final paper?
Interesting data often gets overlooked. By publishing it as a data note in BMC Research Notes it can be found in PubMed, SCImago, Scopus and other indexing services.
Find out which formats we accept and how easy it is to free your data.
BMC Cardiovascular Disorders traveled to Paris to attend the European Society of Cardiology (ESC) 2019 Congress held together with the World Congress of Cardiology. The overarching theme communicated to nearly 33,000 health professional delegates from 146 different countries was “Global cardiovascular health”. Editor Ciarán Fitzpatrick highlight some of our most impactful moments from Congress.
The editors and staff of BMC Cardiovascular Disorders would like to warmly thank the reviewers whose comments helped to shape the journal, for their invaluable assistance with review of manuscripts in Volume 18 (2018).
Aims and scope
Read the published content in this thematic series covering all aspects of research into Sudden Cardiac Death from next-generation sequencing methods to eHealth-based interventions.
Ciarán Martin Fitzpatrick, BioMed Central, UK
- Fabrizio D'ascenzo, University of Turin, IT
- Michel Noutsias, University Hospital of Jena, DE
- Barry Palmer, University of Otago, NZ
Sarah Gray, BioMed Central, UK
Click here to view which Articles have been shared the most in the last month!
Dr Palmer is a Senior Research Fellow at the Christchurch Heart Institute of the Department of Medicine, University of Otago Christchurch and a Senior Lecturer at the School of Health Sciences, Massey University Wellington, New Zealand. He completed a PhD in Molecular Microbiology from the University of Otago Dunedin’s Division of Health Sciences and undertook postdoctoral studies at University of Massachusetts Medical Center, Worcester MA. Barry’s research interests include evaluation of genetic and plasma biomarkers of prognosis in cardiovascular disease cohorts. He serves as Section Editor for Epidemiology.